UniProt ID | MTOR_MOUSE | |
---|---|---|
UniProt AC | Q9JLN9 | |
Protein Name | Serine/threonine-protein kinase mTOR | |
Gene Name | Mtor | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2549 | |
Subcellular Localization |
Endoplasmic reticulum membrane Peripheral membrane protein Cytoplasmic side . Golgi apparatus membrane Peripheral membrane protein Cytoplasmic side . Mitochondrion outer membrane Peripheral membrane protein Cytoplasmic side . Lysosome . Cytopl |
|
Protein Description | Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals. MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor. In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1. To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A. mTORC1 also negatively regulates autophagy through phosphorylation of ULK1. Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1. Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP. mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor. Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules. As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton. Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1. mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B. mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422'. Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms. [PubMed: 19440205] | |
Protein Sequence | MLGTGPAVATASAATSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNSTRIGRFANYLRNLLPSSDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQPNALVGLLGYSSPQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRSSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKTVQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVASITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSQGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEVPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSSQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAASGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKEDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTAHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAASAAAATSTEGSNSESEAESNENSPTPSPLQKKVTEDLSKTLLLYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRTTCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKAGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MLGTGPAV -------CCCCCCCC | 35.87 | - | |
117 | Phosphorylation | YLRNLLPSSDPVVME HHHHHCCCCCHHHHH | 47.55 | 24723360 | |
230 | Malonylation | REPKEMQKPQWYRHT CCCHHHCCCHHHHHH | 37.55 | 26320211 | |
230 | Ubiquitination | REPKEMQKPQWYRHT CCCHHHCCCHHHHHH | 37.55 | - | |
243 | Ubiquitination | HTFEEAEKGFDETLA HHHHHHHHCCCHHHH | 72.44 | 22790023 | |
298 | Ubiquitination | QQQLVHDKYCKDLMG HHHHHCHHHHHHHCC | 37.36 | 22790023 | |
484 | Phosphorylation | QVDATVFTCISMLAR CCCHHHHHHHHHHHH | 12.47 | 28059163 | |
487 | Phosphorylation | ATVFTCISMLARAMG HHHHHHHHHHHHHHC | 15.19 | 28059163 | |
498 | Ubiquitination | RAMGPGIQQDIKELL HHHCCCHHHHHHHHH | 40.59 | 27667366 | |
536 | Ubiquitination | PQLKKDIQDGLLKML HHHHHHHHHHHHHHH | 49.18 | 27667366 | |
567 | Phosphorylation | GLAHQLASPGLTTLP CHHHHHCCCCCCCCC | 28.26 | 26745281 | |
571 | Phosphorylation | QLASPGLTTLPEASD HHCCCCCCCCCCHHH | 32.00 | 26643407 | |
572 | Phosphorylation | LASPGLTTLPEASDV HCCCCCCCCCCHHHH | 45.41 | 26643407 | |
809 | Phosphorylation | IGELAQVSGLEMRKW HHHHHHHCCCCHHHH | 26.11 | 23737553 | |
858 | Phosphorylation | TGYVVEPYRKYPTLL CCCCCCCHHHCHHHH | 13.26 | 21454597 | |
861 | Phosphorylation | VVEPYRKYPTLLEVL CCCCHHHCHHHHHHH | 7.76 | - | |
880 | Phosphorylation | KTEQNQGTRREAIRV HHHCCCCCHHHHHHH | 19.45 | - | |
898 | Ubiquitination | LGALDPYKHKVNIGM HHHCCCCCCCCCEEC | 42.19 | 22790023 | |
900 | Ubiquitination | ALDPYKHKVNIGMID HCCCCCCCCCEECCC | 32.59 | 22790023 | |
1162 | Phosphorylation | IIHPIVRTLDQSPEL HHHHHHHCCCCCHHH | 24.64 | 29895711 | |
1166 | Phosphorylation | IVRTLDQSPELRSTA HHHCCCCCHHHHHHH | 21.73 | 29895711 | |
1218 | Acetylation | VLICRIVKGYTLADE EEEEEEECCCCCCCC | 43.77 | 23806337 | |
1218 | Ubiquitination | VLICRIVKGYTLADE EEEEEEECCCCCCCC | 43.77 | 27667366 | |
1218 | Malonylation | VLICRIVKGYTLADE EEEEEEECCCCCCCC | 43.77 | 26320211 | |
1239 | Phosphorylation | YQHRMLRSSQGDALA HHHHHHHHCCCCHHH | 24.05 | 29472430 | |
1240 | Phosphorylation | QHRMLRSSQGDALAS HHHHHHHCCCCHHHC | 31.58 | 29472430 | |
1247 | Phosphorylation | SQGDALASGPVETGP CCCCHHHCCCCCCCC | 44.47 | 29472430 | |
1256 | Ubiquitination | PVETGPMKKLHVSTI CCCCCCCCEEEEEEE | 56.15 | 22790023 | |
1257 | Ubiquitination | VETGPMKKLHVSTIN CCCCCCCEEEEEEEE | 37.26 | 22790023 | |
1261 | Phosphorylation | PMKKLHVSTINLQKA CCCEEEEEEEEHHHH | 16.90 | 25521595 | |
1262 | Phosphorylation | MKKLHVSTINLQKAW CCEEEEEEEEHHHHH | 16.88 | 27818261 | |
1293 | Ubiquitination | RLSLELLKDSSSPSL HHHHHHHCCCCCHHH | 69.09 | 22790023 | |
1400 | Ubiquitination | YAKALHYKELEFQKG HHHHHCHHHHCCCCC | 45.11 | 22790023 | |
1406 | Ubiquitination | YKELEFQKGPTPAIL HHHHCCCCCCCHHHH | 72.65 | 22790023 | |
1415 | Phosphorylation | PTPAILESLISINNK CCHHHHHHHHHCCCC | 27.79 | 21743459 | |
1418 | Phosphorylation | AILESLISINNKLQQ HHHHHHHHCCCCCCC | 25.26 | 21743459 | |
1430 | Phosphorylation | LQQPEAASGVLEYAM CCCHHHHHHHHHHHH | 36.16 | - | |
1465 | Ubiquitination | DALVAYDKKMDTNKE HHHHHHHHCCCCCCC | 37.00 | 22790023 | |
1471 | Ubiquitination | DKKMDTNKEDPELML HHCCCCCCCCHHHHH | 66.63 | 22790023 | |
1511 | Ubiquitination | VNDETQAKMARMAAA CCHHHHHHHHHHHHH | 24.23 | 22790023 | |
1650 | Ubiquitination | VVSPHEDMRTWLKYA CCCCCHHHHHHHHHH | 3.61 | 27667366 | |
1655 | Ubiquitination | EDMRTWLKYASLCGK HHHHHHHHHHHHCCH | 30.27 | 22790023 | |
1821 | Phosphorylation | KKKLRHASGANITNA HHHHHHHCCCCCCCH | 32.11 | 25293948 | |
1826 | Phosphorylation | HASGANITNATTAAT HHCCCCCCCHHHHHH | 20.71 | 25293948 | |
1829 | Phosphorylation | GANITNATTAATTAA CCCCCCHHHHHHHHH | 21.02 | 25293948 | |
1830 | Phosphorylation | ANITNATTAATTAAS CCCCCHHHHHHHHHH | 16.34 | 25293948 | |
1833 | Phosphorylation | TNATTAATTAASAAA CCHHHHHHHHHHHHH | 17.95 | 25293948 | |
1834 | Phosphorylation | NATTAATTAASAAAA CHHHHHHHHHHHHHH | 18.59 | 25293948 | |
1837 | Phosphorylation | TAATTAASAAAATST HHHHHHHHHHHHHCC | 18.90 | 25293948 | |
1842 | Phosphorylation | AASAAAATSTEGSNS HHHHHHHHCCCCCCC | 31.30 | 25293948 | |
1843 | Phosphorylation | ASAAAATSTEGSNSE HHHHHHHCCCCCCCH | 21.53 | 25293948 | |
1844 | Phosphorylation | SAAAATSTEGSNSES HHHHHHCCCCCCCHH | 39.76 | 25293948 | |
1847 | Phosphorylation | AATSTEGSNSESEAE HHHCCCCCCCHHHHH | 30.83 | 19060867 | |
1849 | Phosphorylation | TSTEGSNSESEAESN HCCCCCCCHHHHHCC | 44.17 | 25293948 | |
1851 | Phosphorylation | TEGSNSESEAESNEN CCCCCCHHHHHCCCC | 41.76 | 19060867 | |
1855 | Phosphorylation | NSESEAESNENSPTP CCHHHHHCCCCCCCC | 57.39 | 25293948 | |
1859 | Phosphorylation | EAESNENSPTPSPLQ HHHCCCCCCCCCHHH | 24.79 | 25293948 | |
1861 | Phosphorylation | ESNENSPTPSPLQKK HCCCCCCCCCHHHHH | 35.90 | 25293948 | |
1893 | Phosphorylation | QGFFRSISLSRGNNL HHHHHHHCCCCCCCH | 22.87 | 22006019 | |
2066 | Ubiquitination | ERGPQTLKETSFNQA HHCCCCHHHCCHHHH | 63.43 | 22790023 | |
2069 | Phosphorylation | PQTLKETSFNQAYGR CCCHHHCCHHHHHCH | 24.24 | 23684622 | |
2159 | Phosphorylation | RIQSIAPSLQVITSK EEECCCCCCEEECCC | 23.55 | - | |
2164 | Phosphorylation | APSLQVITSKQRPRK CCCCEEECCCCCCCE | 30.89 | - | |
2173 | Phosphorylation | KQRPRKLTLMGSNGH CCCCCEEEEECCCCC | 20.10 | - | |
2370 | Ubiquitination | EVAMTREKFPEKIPF HHHHCCCCCCCCCCH | 64.03 | 22790023 | |
2442 | Phosphorylation | NTKGNKRSRTRTDSY CCCCCCCCCCCCCCC | 39.34 | 22322096 | |
2444 | Phosphorylation | KGNKRSRTRTDSYSA CCCCCCCCCCCCCCC | 38.88 | 25619855 | |
2446 | Phosphorylation | NKRSRTRTDSYSAGQ CCCCCCCCCCCCCCC | 28.78 | 25619855 | |
2448 | Phosphorylation | RSRTRTDSYSAGQSV CCCCCCCCCCCCCCE | 22.00 | 19643477 | |
2449 | Phosphorylation | SRTRTDSYSAGQSVE CCCCCCCCCCCCCEE | 12.83 | 25619855 | |
2450 | Phosphorylation | RTRTDSYSAGQSVEI CCCCCCCCCCCCEEE | 29.85 | 25619855 | |
2454 | Phosphorylation | DSYSAGQSVEILDGV CCCCCCCCEEECCCC | 22.31 | 22322096 | |
2473 | Phosphorylation | PAHKKAGTTVPESIH CCHHHCCCCCCHHHH | 29.49 | 26824392 | |
2474 | Phosphorylation | AHKKAGTTVPESIHS CHHHCCCCCCHHHHH | 32.90 | 27087446 | |
2478 | Phosphorylation | AGTTVPESIHSFIGD CCCCCCHHHHHHHCC | 21.38 | 25521595 | |
2481 | Phosphorylation | TVPESIHSFIGDGLV CCCHHHHHHHCCCCC | 19.52 | 20138985 | |
2496 | Ubiquitination | KPEALNKKAIQIINR CHHHCCHHHHHHHHH | 50.04 | 22790023 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2173 | T | Phosphorylation | Kinase | AKT1 | P31750 | Uniprot |
2446 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
2446 | T | Phosphorylation | Kinase | RPS6KB1 | Q8BSK8 | Uniprot |
2446 | T | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
2446 | T | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
2448 | S | Phosphorylation | Kinase | RPS6KB1 | Q8BSK8 | Uniprot |
2481 | S | Phosphorylation | Kinase | MTOR | Q9JLN9 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTOR_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FKB1A_HUMAN | FKBP1A | physical | 9334222 | |
RICTR_MOUSE | Rictor | physical | 20801936 | |
IKKA_MOUSE | Chuk | physical | 22351927 | |
LST8_HUMAN | MLST8 | physical | 18235224 | |
RPTOR_HUMAN | RPTOR | physical | 18235224 | |
DDB1_HUMAN | DDB1 | physical | 18235224 | |
RICTR_HUMAN | RICTOR | physical | 18235224 | |
KS6B1_MOUSE | Rps6kb1 | physical | 17386266 | |
RICTR_MOUSE | Rictor | physical | 18664580 | |
RICTR_MOUSE | Rictor | physical | 18851840 | |
LST8_MOUSE | Mlst8 | physical | 18851840 | |
MLXIP_MOUSE | Mlxip | physical | 25332233 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Site-specific mTOR phosphorylation promotes mTORC1-mediated signalingand cell growth."; Acosta-Jaquez H.A., Keller J.A., Foster K.G., Ekim B., Soliman G.A.,Feener E.P., Ballif B.A., Fingar D.C.; Mol. Cell. Biol. 29:4308-4324(2009). Cited for: PHOSPHORYLATION AT SER-1261, AND ENZYME REGULATION. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2481, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2478 AND SER-2481, ANDMASS SPECTROMETRY. |